Literature DB >> 22188930

Smallpox and its eradication in the Democratic Republic of Congo: lessons learned.

Jean-Jacques Muyembe-Tamfum1, Prime Mulembakani, René Botee Lekie, Mark Szczeniowski, Zdeněk Ježek, Reena Doshi, Nicole Hoff, Anne W Rimoin.   

Abstract

Smallpox eradication is considered to be one of the most remarkable accomplishments of the 20th century. Lessons learned from the campaign during the 1960s and 1970s in the Democratic Republic of Congo (DRC) can provide important information for the development of other eradication programs including polio. The DRC is the third largest country in Africa; the population suffers from extreme poverty, deteriorating infrastructure and health systems, and long periods of civil strife. Despite these challenges, DRC's smallpox eradication campaign was successful, eradicating smallpox only 41 months after initiation. DRC had been polio free since 2001; however, in 2006, imported cases were identified in the country. Polio transmission has since been re-established and DRC now has the second greatest number of reported polio cases in the world. Challenges which existed during the smallpox campaign in DRC are still present today; additionally, the polio vaccine itself poses unique challenges which include requiring multiple doses to confer immunity. In the fight against polio in DRC, it will be important to draw from the smallpox eradication experience. A number of important themes emerged during the campaign that could be beneficial to eradicating polio and future eradication programs that may follow. During the smallpox campaign, a standard vaccination program was implemented, surveillance was intensified, and there were strong collaborative programs with community involvement. These successful elements of the smallpox campaign should be adapted and applied in DRC in polio eradication programs.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22188930     DOI: 10.1016/j.vaccine.2011.10.049

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  5 in total

1.  Discovery and Description of Ebola Zaire Virus in 1976 and Relevance to the West African Epidemic During 2013-2016.

Authors:  Joel G Breman; David L Heymann; Graham Lloyd; Joseph B McCormick; Malonga Miatudila; Frederick A Murphy; Jean-Jacques Muyembé-Tamfun; Peter Piot; Jean-François Ruppol; Pierre Sureau; Guido van der Groen; Karl M Johnson
Journal:  J Infect Dis       Date:  2016-06-29       Impact factor: 5.226

2.  Assessment of attitudes towards adverse events following immunization with oral poliovirus vaccine: a pilot study among high school students of Kinshasa, the Democratic Republic of Congo.

Authors:  Léon Kinuani; Didier Bomene Nzolo; Michel Ntetani Aloni; Pavel Makolo; Nsengi Ntamabyaliro; Yves Lula Ntamba; Crispin Kazadi; Michel Nyembwe; Mathilde Bothale Ekila; Gauthier Kahunu Mesia
Journal:  Pathog Glob Health       Date:  2014-09-19       Impact factor: 2.894

3.  Political will and international collaborative frameworks in infectious diseases.

Authors:  R A Stein
Journal:  Int J Clin Pract       Date:  2015-01       Impact factor: 2.503

Review 4.  Monkeypox: Some Keys to Understand This Emerging Disease.

Authors:  Esperanza Gomez-Lucia
Journal:  Animals (Basel)       Date:  2022-08-25       Impact factor: 3.231

5.  NTDs in the heart of darkness: the Democratic Republic of Congo's unknown burden of neglected tropical diseases.

Authors:  Anne W Rimoin; Peter J Hotez
Journal:  PLoS Negl Trop Dis       Date:  2013-07-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.